je.st
news
Bristol-Myers Squibb To Acquire Padlock Therapeutics, Inc.
2016-03-30 03:53:43| drugdiscoveryonline Home Page
Bristol-Myers Squibb Company and Padlock Therapeutics, Inc. announced recently that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of Padlock, a private, Cambridge, Massachusetts-based biotechnology company dedicated to creating new medicines to treat destructive autoimmune diseases
Tags: acquire
therapeutics
squibb
padlock
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||